Northern Trust’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-29
Closed -$13K 4742
2021
Q2
$13K Sell
29
-21
-42% -$10.5K ﹤0.01% 4552
2021
Q1
$28K Hold
50
﹤0.01% 4424
2020
Q4
$29K Sell
50
-2
-4% -$993 ﹤0.01% 4292
2020
Q3
$16K Sell
52
-8
-13% -$2.78K ﹤0.01% 4236
2020
Q2
$20K Sell
60
-4
-6% -$915 ﹤0.01% 4170
2020
Q1
$11K Sell
64
-3
-4% -$471 ﹤0.01% 4145
2019
Q4
$10K Hold
67
﹤0.01% 4197
2019
Q3
$12K Hold
67
﹤0.01% 4184
2019
Q2
$19K Buy
67
+1
+2% +$357 ﹤0.01% 4174
2019
Q1
$28K Sell
66
-2
-3% -$825 ﹤0.01% 4098
2018
Q4
$23K Sell
68
-1
-1% -$463 ﹤0.01% 4138
2018
Q3
$41K Buy
69
+8
+13% +$5.21K ﹤0.01% 4158
2018
Q2
$46K Buy
+61
New +$44K ﹤0.01% 4131
2016
Q3
Sell
-126
Closed -$214K 4209
2016
Q2
$214K Hold
126
﹤0.01% 3704
2016
Q1
$217K Buy
+126
New +$201K ﹤0.01% 3702
2015
Q4
Sell
-1,926
Closed -$3.31M 4318
2015
Q3
$3.31M Buy
1,926
+25
+1% +$60.3K ﹤0.01% 2729
2015
Q2
$5.15M Buy
1,901
+40
+2% +$104K ﹤0.01% 2498
2015
Q1
$5.37M Buy
1,861
+452
+32% +$1.25M ﹤0.01% 2465
2014
Q4
$3.7M Sell
1,409
-42
-3% -$109K ﹤0.01% 2686
2014
Q3
$3.98M Buy
1,451
+1,384
+2,066% +$4.5M ﹤0.01% 2662
2014
Q2
$232K Sell
67
-816
-92% -$2.9M ﹤0.01% 3818
2014
Q1
$3.21M Buy
+883
New +$3.47M ﹤0.01% 2845

Other funds holding TRIB

Northern Trust's TRIB Position: Q3 2021 in Review

Northern Trust sold out of Trinity Biotech (TRIB) in Q3 2021, closing a stake of 29 shares — an estimated $13K sold.

Northern Trust first reported a position in TRIB in Q1 2014 and held it in 22 quarters. The position peaked at $5.37M in Q1 2015. 21 funds tracked by Wall St. Rank hold TRIB as of Q3 2021.

  • Northern Trust reported no remaining Trinity Biotech position as of Q3 2021 after selling out during the quarter.
  • Northern Trust sold 29 Trinity Biotech shares in Q3 2021, an estimated $13K.
  • Northern Trust first reported a position in Trinity Biotech in Q1 2014 and held it in 22 quarters.
  • Northern Trust's Trinity Biotech position peaked at $5.37M in Q1 2015.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2021.

Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.